A day after Serum Institute of India’s Covishield was flown to 13 different cities in India from Pune, a shipment of Bharat Biotech’s Covaxin from Hyderabad landed at Delhi airport.
Bharat Biotech’s shipment was transported by Air India on AI 559 from Hyderabad to Delhi at 6:40 a.m. on Wednesday.
On Tuesday, the first shipment of COVID-19 “Covishield” vaccine arrived at Indira Gandhi International Airport in Delhi from Pune.
Meanwhile, Maharashtra has received over 9 lakh lakhs doses of IBS’s COVID-19 “Covishield” vaccine.
Covishield and Covaxin, the two COVID-19 vaccines that have received Emergency Use Authorization (EAU) have been tested on thousands of people and the side effects are negligible, Dr VK Paul, member (Health ), NITI Aayog, adding that both “are the safest of vaccines.”
“Both vaccines (Covishield and Covaxin) have been authorized for emergency use and there should be no doubt as to their safety. They have been tested on thousands of people and the side effects are negligible. There is no risk of any importance, ”Dr Paul said at a press conference.
The first phase of the COVID-19 vaccination campaign is scheduled for January 16.
Health Secretary Rajesh Bhushan said the central government is working closely with states and Union territories for vaccine deployment. “All preparations are on track for vaccine deployment from January 16,” he said.
Prime Minister Narendra Modi previously said around 3 million healthcare and frontline workers would be vaccinated in the first phase of vaccination.
“In the second phase, people over 50 and those under 50 with comorbidities will be vaccinated,” he added.
(With contributions from the agency)